AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL __, 2001
                                                      REGISTRATION NO. _________
================================================================================
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                                 --------------
                    INNOVATIVE HOLDINGS & TECHNOLOGIES, INC.
              -----------------------------------------------------
             (Exact name of registrant as specified in its charter)

              Colorado                                  74-2929034
- ------------------------------------          -------------------------------
   (State or other jurisdiction of                     (IRS Employer
   incorporation or organization)                  Identification Number

                             100 South Orange Avenue
                                    Suite 300
                                Orlando, FL 32801
              ----------------------------------------------------
                    (Address of Principal Executive Offices)

                              Chairman Compensation
                    ----------------------------------------
                            (Full title of the Plan)

                             -----------------------

                                  Helmut Wyzisk
                             Chairman and President
                             100 South Orange Avenue
                                    Suite 300
                                Orlando, FL 32801
               --------------------------------------------------
                     (Name and address of agent for service)

                                 (407) 481-8900
          -------------------------------------------------------------
          (Telephone number, including area code, of agent for service)

                               -------------------

                         CALCULATION OF REGISTRATION FEE

============================= ===================== ====================== ===================== =====================
                                                      Proposed maximum           Proposed
    Title of securities           Amount to be         offering price       maximum aggregate         Amount of
      to be registered             registered           per share (1)       offering price (1)     registration fee
 ............................. ..................... ...................... ..................... .....................
                                                                                     

Common stock,                      10,000,000
   $.001 par value                   shares                 $0.07                $700,000                $175
============================= ===================== ====================== ===================== =====================


(1) The registration fee was computed in accordance with Rule 457(h).






REOFFER/RESALE PROSPECTUS

                    INNOVATIVE HOLDINGS & TECHNOLOGIES, INC.

                10,000,000 SHARES COMMON STOCK ($.001 PAR VALUE)


         This  prospectus is being used in connection with the reoffer or resale
from  time to time of up to  10,000,000  shares  of our  common  stock by Helmut
Wyzisk of Innovative Holdings & Technologies,  Inc. (named under the caption and
hereafter  referred  to  as  "Selling  Shareholder").  The  Selling  Shareholder
acquired the common  stock as  compensation  for his  employment  by  Innovative
Holdings & Technologies, Inc.

         The Selling  Shareholder may sell the common stock from time to time in
one or more transactions  (which may involve one or more block  transactions) in
sales  occurring  in the public  market,  in privately  negotiated  transactions
(including sales pursuant to pledges), or in a combination of such transactions.
Each sale may be made  either at market  prices  prevailing  at the time of such
sale, at negotiated prices or at fixed prices, which may be changed. Some or all
of the shares of common  stock may be sold through  brokers  acting on behalf of
the  Selling  Shareholder  or to  dealers  for  resale by such  dealers;  and in
connection with such sales, such brokers or dealers may receive  compensation in
the form of discounts,  fees or commissions from the Selling  Shareholder and/or
the  purchasers  of the shares  for whom they may act as broker or agent  (which
discounts,  fees or commissions  may be in excess of those customary in the type
of transaction  involved).  However,  any shares of common stock covered by this
prospectus  that qualify for sale pursuant to Rule 144 under the  Securities Act
of 1933,  as amended,  may be sold under Rule 144 rather  than  pursuant to this
prospectus.

         All expenses of registration  incurred in connection with this offering
are being borne by us, but all brokerage  commissions and other selling expenses
incurred by the Selling  Shareholder  will be borne by him. The shares of common
stock are being sold by the Selling  Shareholder acting as principal for his own
account. We will not be entitled to any of the proceeds from such sales.

         The Selling  Shareholder  and any dealer acting in connection  with the
offering of any of the common stock or any broker  executing  selling  orders on
behalf of the Selling Shareholder may be deemed to be "underwriters"  within the
meaning of the Securities Act of 1933, as amended.  In such event, any profit on
the sale of any or all of the shares by them and any  discounts  or  concessions
received  by any such  brokers  or  dealers  may be  deemed  to be  underwriting
discounts and commissions under the Securities Act of 1933, as amended.

         Our common stock is quoted on the OTC  Electronic  Bulletin Board under
the symbol  "IHTL." On April 12, 2001,  the closing price of the common stock as
reported on the OTC Electronic Bulletin Board was $0.07 per share.

                              --------------------

         Investing in our common stock involves a high degree of risk. See "Risk
Factors" beginning on page 6 of this prospectus.

         Neither the Securities and Exchange Commission nor any state securities
commission  has approved or disapproved  these  securities or determined if this
prospectus  is truthful or  complete.  Any  representation  to the contrary is a
criminal offense.

                  The date of this Prospectus is April 16, 2001

                                       2




                                TABLE OF CONTENTS

                                                                           Page
                                                                           ----

Available Information.........................................................3
Incorporation of Certain Documents by Reference...............................4
The Company...................................................................5
Risk Factors..................................................................5
Use of Proceeds...............................................................7
Selling Shareholder...........................................................7
Plan of Distribution..........................................................8
Legal Matters.................................................................8
Liability of Directors and Officers, Indemnification..........................9
Special Note Regarding Forward-Looking Statements.............................9


                              --------------------


         Our  principal  executive  offices are  located at 100 S. Orange  Ave.,
Suite 300,  Orlando,  Florida 32801, and our telephone number is (407) 481-8900.
The  information  in our Web site is not  incorporated  by  reference  into this
prospectus.  Any reference in this prospectus to "we" or "our" is a reference to
Innovative.

         The  information in this  prospectus is accurate only as of the date of
this  prospectus,  regardless  of the time of delivery of this  prospectus.  You
should assume that the  information  appearing in this prospectus is accurate as
of the date on the front cover of the prospectus.

                              AVAILABLE INFORMATION

         We are subject to the information and periodic  reporting  requirements
of the  Securities  Exchange Act of 1934, as amended (the  "Exchange  Act").  In
accordance with the Exchange Act, we file reports,  proxy statements,  and other
information with the Securities and Exchange Commission (the "Commission"). This
prospectus does not contain all of the information set forth in the registration
statement to which it relates,  certain parts of which are omitted in accordance
with the rules and regulations of the Commission.  Statements  contained in this
prospectus  concerning  the  provisions  of any  document  are  not  necessarily
complete  and,  in each  instance,  reference  is hereby made to the copy of the
document filed as an exhibit to the registration statement.

         The  registration  statement  described  above,  its exhibits,  and the
reports, proxy statements, and other information filed by us with the Commission
can be inspected and copied at the public reference facilities maintained by the
Commission at the Commission's Public Reference Room at 450 Fifth Street,  N.W.,
Washington,  D.C.  20549.  You may obtain  information  on the  operation of the
Public  Reference  Room by calling the Commission at  1-800-SEC-0330.  Copies of
such material may be obtained by mail at prescribed  rates from the Commission's
Public  Reference  Section at its principal  office at 450 Fifth  Street,  N.W.,
Washington,  D.C. 20549.  Such material may also be accessed at the Commission's
home page or the Internet at  http:/www.sec.gov.  The Commission maintains a web
site, the address of which is http:/www.sec.gov that contains reports, proxy and
information  statements and other information regarding  registrants,  including
Innovative, that file electronically with the Commission.


                                       3


                INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

         The  following  documents  filed with the  Commission  pursuant  to the
Exchange Act are incorporated herein by reference:

                  (1) The  Registrant's  Annual  Report on Form  l0-KSB  for the
         fiscal year ended December, 31, 2000.

                  (2)  All  other  reports  filed  by the  Registrant  with  the
         Commission  pursuant to Section  13(a) or Section 15(d) of the Exchange
         Act since the end of the fiscal year covered by the Registrant's Annual
         Report referred to above; and

                  (3) The  description  of the  Common  Stock of the  Registrant
         contained in the Registrant's Registration Statement.

                  All  documents  filed by the  Registrant  with the  Commission
         pursuant  to Section  13(a),  13(c),  14 or 15(d) of the  Exchange  Act
         subsequent to the date of this Registration  Statement and prior to the
         filing of a  post-effective  amendment  hereto which indicates that all
         securities  offered have been sold or which  deregisters all securities
         then remaining unsold,  shall be deemed to be incorporated by reference
         herein  and to be a part  hereof  from  the  date  of  filing  of  such
         documents.

         Any  statement  contained  in a document  incorporated  or deemed to be
incorporated  herein by  reference,  or contained in this  prospectus,  shall be
deemed to be modified or  superseded  for  purposes  of this  prospectus  to the
extent  that a statement  contained  herein or in any other  subsequently  filed
document  which  also is or is deemed to be  incorporated  by  reference  herein
modifies or supersedes such statement.  Any such statement so modified shall not
be deemed to constitute a part of this prospectus except as so modified, and any
statement  so  superseded  shall  not be  deemed  to  constitute  a part of this
prospectus.

We will provide  without charge to each person to whom a copy of this prospectus
is delivered,  upon the written or oral request of such person, a copy of any or
all documents incorporated by reference into this prospectus except the exhibits
to such  documents  (unless  such  exhibits  are  specifically  incorporated  by
reference in such  documents).  Requests  for such copies  should be directed to
Investor  Relations,  100 South Orange  Avenue,  Suite 300,  Orlando,  FL 32801.
Telephone (407) 481-9800.


                                       4


                                   THE COMPANY

         THE FOLLOWING SUMMARY IS QUALIFIED IN ITS ENTIRETY BY THE MORE DETAILED
INFORMATION AND FINANCIAL  STATEMENTS AND NOTES THERETO  APPEARING  ELSEWHERE IN
THIS PROSPECTUS OR INCORPORATED HEREIN BY REFERENCE.

         Innovative Holdings & Technologies,  Inc. (the "Company" or "IHTL") was
incorporated under the laws of the State of Colorado on January 7, 1987. We have
one operating  subsidiary named Xtreme Telemetry Systems,  Inc. (XTS), a Florida
corporation.

         We are in the  business of  acquiring,  creating  and  developing  high
technology companies with promising new technologies and applications. We do not
intend to combine  with private  companies  in manners  which may cause it to be
deemed an investment company subject to the Investment Company Act of 1940.

         Through our XTS  subsidiary,  we have  developed  the Xtreme  Telemetry
System,  a high  technology  data  acquisition and delivery system for broadcast
television  and  Internet  applications.  The  XTS  System  incorporates  sensor
technologies  to  gather  data from  biological,  mechanical  and  environmental
sources. This data then can be wirelessly transmitted from its source, by way of
XTS's  proprietary  software,  to broadcast  applications on TV or the Internet.
This  broadcast  information  can  then be  graphically  displayed  on TV or the
Internet.

         During 2000 there was contact  with sports and  broadcast  entities for
the  purpose  of  telemetry  data  acquisition  and  broadcast  delivery.  These
discussions  have not  resulted  in  contractual  agreements  and  there  are no
assurances that these efforts will be successful.

          We have  developed  propriety  software for which a copyright has been
applied for.

          We  acquired  an  interest  in USTech  Materials  Corporation.  USTech
Materials  Corporation (USTM) intends to develop manufacturing and marketing for
Poly Ether Amid  Resin,  also known as PEAR.  The PEAR  resins  were  originally
developed by Ashland,  Inc., who entered into a license agreement with USTM/IHTL
in July, 2000. The Company has endeavored to seek out financing and personnel to
assist  USTM's  infrastructure,  sales,  and  marketing  systems  and  strategic
relationships  in order to bring  PEAR to the  marketplace.  We are still in its
basic  development   stages,   and  there  are  no  guarantees  that  USTM  will
successfully raise sufficient  capital,  attract management and other personnel,
and  be  able  to  develop  manufacturing  facilities,  materials  sources,  R&D
capabilities, marketing channels and delivery methods for PEAR resins.

                                  RISK FACTORS

         You should carefully  consider the following risk factors and all other
information  contained in this prospectus or  incorporated  herein by reference.
Investing in  Innovative's  common stock  involves a high degree of risk. Any of
the following  risks could  materially  harm  Innovative's  business,  operating
results and  financial  condition  and could  result in a complete  loss of your
investment.

RISKS RELATED TO OUR BUSINESS

We have a  limited  operating  history  which  may not be a  reliable  basis for
evaluating our prospects.

         We are a  development  stage company with a limited  operating  history
upon  which  you  can  evaluate  us and our  potential.  Our  prospects  must be
considered  in  light  of  the  risks,  expenses,  and  difficulties  frequently
encountered  by  companies  in  an  early  stage  of  development,  particularly
companies  in new and  rapidly  evolving  markets  like  ours.  Our  failure  to
successfully address these risks and uncertainties could have a material adverse
effect on our financial condition.


                                       5


We expect future losses.

         To date, we have  generated no revenues from  operations,  and have had
net  losses.  We may be  unable  to be  profitable,  and if we  are,  we may not
maintain profitability in the future.

We will require additional capital which may not be available to us.

         Our expansion and development plans will consume substantial amounts of
capital.  We must raise  significant  additional  funds  through  debt or equity
financing.  We also  anticipate  that our funding  needs will  continue into the
future.  Adequate funds may not be available when needed or may not be available
on favorable terms. If we raise  additional funds by issuing equity  securities,
dilution to existing  Shareholders may result. If funding is insufficient at any
time, we may be unable to produce our programs, develop or enhance our libraries
or services, take advantage of business opportunities, or respond to competitive
pressures,  any of which could harm our business.  Our capital requirements will
depend upon many factors, including, but not limited to:

         o  the rate at which we develop our operations; and
         o  the extent to which we develop and brand our  products and services.

We may be unable to recruit and retain the personnel we need to succeed.

         We may be unable to retain our key employees  and key sales  affiliates
or attract,  assimilate  or retain other highly  qualified  employees  and sales
affiliates in the future.  Our future success depends on our ability to attract,
retain and motivate highly skilled employees and sales affiliates. Particularly,
if we do not succeed in attracting new personnel or retaining and motivating our
current  personnel,  it may be difficult  for us to manage our business and meet
our objectives.

We are dependent on our key management personnel for our future success.

         Our future success  depends to a significant  extent on the efforts and
ability of our management team,  particularly Helmut Wyzisk, our Chief Executive
Officer.  The departure of any of our officers or key  employees  could harm our
ability to implement our business plan.

Our officers and directors have significant influence over us.

         Our executive  officers and directors,  in the aggregate,  beneficially
own a significant percentage of our common stock. These Shareholders may be able
to exercise  control over all matters  requiring  approval by our  Shareholders,
including  the  election of  directors  and  approval of  significant  corporate
transactions.  This  concentration  of  ownership  may also  have the  effect of
delaying or  preventing  a change in control of us,  which could have a material
adverse effect on our stock price.

We may be liable for infringing the intellectual property rights of others.

         We may receive in the future, notice of claims of infringement of other
parties'  proprietary rights.  Infringement or other claims could be asserted or
prosecuted  against  us in the  future  and it is  possible  that past or future
assertions or  prosecutions  could harm our business.  Any such claims,  with or
without  merit,  could be time  consuming,  resulting in costly  litigation  and
diversion of technical and management personnel, cause delays in the development
and release of new products or services, or require us to develop non-infringing
technology  or enter into  royalty or  licensing  arrangements.  Such royalty or
licensing arrangements, if required, may not be available on terms acceptable to
us, or at all. For these reasons, infringement claims could harm our business.

Our failure to protect our  intellectual  property  could  adversely  affect our
brand and our business.

         We will need to rely on a  combination  of trademark  and copyright law
and trademark protection. Despite our efforts, we cannot be sure that we will be
able to prevent  misappropriation of our intellectual  property.  It is possible
that  litigation  may be  necessary  in the future to enforce  our  intellectual
property  rights,  to protect our trade secrets or to determine the validity and
scope  of  the  proprietary  rights  of  others.   Litigation  could  result  in
substantial  costs and diversion of our resources away from the operation of our
business.


                                       6





Effect of anti-takeover laws.

         Certain  provisions  of Colorado  law may deter or frustrate a takeover
attempt of the Company that Shareholders might consider in its best interest.

RISKS RELATED TO THE INTERNET INDUSTRY

Our  business  will  suffer  if we fail  to  adapt  to  evolving  standards  and
technologies.

         The  standards  and  technologies  that  make up data  acquisition  and
delivery  will  evolve and  change  over time.  We must  adapt our  services  to
maintain  compatibility  in the future to assure that we can continue to deliver
high  quality  services in the sports  industry.  Our  inability to deliver high
quality services would lead to a decline in the demand for our services.

Third party  breaches of database  security  could  disrupt our  operations  and
increase our capital expenditures.

         A  party  who  is  able  to  circumvent  our  security  measures  could
misappropriate  proprietary  database  information or cause interruptions in our
operations.  As a result we may be  required to expend  significant  capital and
other  resources  to protect  against  such  security  breaches or to  alleviate
problems caused by such breaches, which could harm our business.

                                 USE OF PROCEEDS

         This  prospectus  relates to shares of common  stock being  offered and
sold  for the  account  of the  Selling  Shareholder.  We will not  receive  any
proceeds from the sale of the common stock but will pay all expenses  related to
the registration of the shares.

                               SELLING SHAREHOLDER

         The Selling  Shareholder whose shares are covered by this prospectus is
our President and  Chairman.  The following  table shows the name of the Selling
Shareholder  and the  position he has held with us during the past three  years,
the number of shares of our common stock that he beneficially  owned as of April
16, 2001, the number of shares of common stock covered by this  prospectus,  and
the number of shares of common  stock the  Selling  Shareholder  will hold if he
sells all of the shares offered by this prospectus.

        Selling                Position with          Beneficial Ownership         Shares       Beneficial Ownership
     Shareholders               the Company              Before Offering          Offered          After Offering
     ------------               -----------              ---------------          -------          --------------
                                                                                    
    Helmut Wyzisk           Chairman/President            17,021,500 (1)        10,000,000            7,021,500


(1)      Includes   6,000,000   shares  of  common  stock   underlying   options
         exercisable at $.05 per share


                                       7


                              PLAN OF DISTRIBUTION

         Since the Selling  Shareholder  may from time to time offer all or part
of the  shares,  and since this  offering  is not being  underwritten  on a firm
commitment  basis,  no  estimate  can be given as to the  amount of shares to be
offered for sale by the Selling Shareholder.

         The  Selling  Shareholder  may  sell or  distribute  some or all of the
shares  offered by this  prospectus  from time to time through  underwriters  or
dealers  or  brokers  or other  agents or  directly  to one or more  purchasers,
including  pledgees,  in transactions  (which may involve block transactions) in
sales  occurring  in the public  market,  in privately  negotiated  transactions
(including sales pursuant to pledges) or in a combination of such  transactions.
Such  transactions  may be effected by the Selling  Shareholder at market prices
prevailing at the time of sale, at negotiated prices, or at fixed prices,  which
may be changed.  Some or all of the shares may be sold through brokers acting on
behalf of the Selling Shareholder or to dealers for resale by such dealers;  and
in connection with such sales, such brokers or dealers may receive  compensation
in the form of  discounts,  fees or  commissions  from the  Selling  Shareholder
and/or the  purchasers  of such shares for whom they may act as broker or agent.
Such discounts,  concessions or commissions as to a particular broker, dealer or
agent might be in excess of those customary in the type of transaction involved.
This  prospectus  also may be used,  with our consent,  by donees of the Selling
Shareholder, or by other persons acquiring shares and who wish to offer and sell
such  shares  under  circumstances  requiring  or making  desirable  its use. In
addition,  any shares covered by this prospectus which qualify for sale pursuant
to Rule 144 of the  Securities Act of 1933, as amended (the  "Securities  Act"),
may be sold under Rule 144 rather than pursuant to this prospectus.

         Under  applicable  rules and  regulations  under the Exchange  Act, any
person  engaged in a  distribution  of any of the shares may not  simultaneously
engage in market  activities  with  respect to the common  stock for a period of
five business days prior to the commencement of such  distribution.  In addition
and without limiting the foregoing,  the Selling  Shareholder will be subject to
applicable  provisions  of the  Exchange  Act  and  the  rules  and  regulations
thereunder,  including,  without limitation,  Rule 10b-5 and Regulation M, which
provisions  may limit the timing of purchases  and sales of any of the shares by
the Selling  Shareholder.  All of the  foregoing may affect the marketing of the
common stock.

         The Selling  Shareholder  and any dealer acting in connection  with the
offering of any of the shares or any broker  executing  selling orders on behalf
of the Selling Shareholder may be deemed to be "underwriters" within the meaning
of the  Securities  Act,  in which event any profit on the sale of any or all of
the shares by them and any discounts or concessions received by any such brokers
or dealers may be deemed to be underwriting  discounts and commissions under the
Securities Act.

         In order to comply  with the  securities  laws of  certain  states,  if
applicable,  the  shares  will  be  sold  in  such  jurisdictions  only  through
registered or licensed brokers or dealers.

                                  LEGAL MATTERS

         The validity of the common stock offered hereby will be passed upon for
Innovative  by Jonathan D.  Leinwand,  P.A. No members of Jonathan D.  Leinwand,
P.A., own any beneficial interest in Innovative.


                                       8


              LIABILITY OF DIRECTORS AND OFFICERS, INDEMNIFICATION

         Innovative'  articles of  incorporation,  as amended,  provide that the
Company may indemnify any director,  officer,  employee,  fiduciary, or agent of
the Company to the full extent  permitted by Section 109 of the Colorado Revised
Statutes as in effect at the time of the conduct by the person.

         An officer or director  of a Colorado  corporation  may be  indemnified
against  liability  occurred in any proceeding  related to that person's actions
while acting as an officer or director of the  corporation  if that person acted
in good faith; in the corporation's best interest or at least not opposed to the
corporation's  best interest;  and the person had no reasonable cause to believe
that his or her conduct was unlawful.

         An officer or director may not be  indemnified in a proceeding by or on
behalf of the  corporation  where the officer or director  was judged  liable or
where the officer or director  received  an  improper  personal  benefit and was
adjudged liable.

         Insofar as indemnification for liabilities arising under the Securities
Act  may  be  permitted  to  directors,  officers  and  controlling  persons  of
Innovative pursuant to the foregoing  provisions,  or otherwise,  Innovative has
been  advised  that in the opinion of the  Commission  such  indemnification  is
against  public  policy as expressed in the  Securities  Act and is,  therefore,
unenforceable.

                SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

         This prospectus contains certain forward-looking  statements within the
meaning of Section 27A of the  Securities  Act,  and Section 21E of the Exchange
Act,  with  respect  to  our  business,   financial  condition  and  results  of
operations.  When used in this prospectus,  the words "may," "will,"  "intends,"
"plans,"  "expects,"  "anticipates,"  "estimates,"  and similar  expressions are
intended to identify forward-looking  statements. The forward-looking statements
included herein are subject to risks and uncertainties. Our actual results could
differ  materially  from  those  discussed  in the  forward-looking  statements.
Factors that could cause or contribute to such differences  include, but are not
limited  to,  those  discussed  in "Risk  Factors,"  as well as those  discussed
elsewhere  in this  prospectus.  Investors  are  cautioned  not to  place  undue
reliance on these  forward-looking  statements,  which speak only as of the date
hereof. Innovative undertakes no obligation to publicly release any revisions to
these  forward-looking  statements to reflect events or circumstances  after the
date hereof or to reflect the occurrence of unanticipated events.


                                       9


           PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3.  INCORPORATION OF DOCUMENTS BY REFERENCE.

                  (1) The  Registrant's  Annual  Report on Form  l0-KSB  for the
         fiscal year ended December, 31, 2000.

                  (2)  All  other  reports  filed  by the  Registrant  with  the
         Commission  pursuant to Section  13(a) or Section 15(d) of the Exchange
         Act since the end of the fiscal year covered by the Registrant's Annual
         Report referred to above; and

                  (3) The  description  of the  Common  Stock of the  Registrant
         contained in the Registrant's Registration Statement.

                  All  documents  filed by the  Registrant  with the  Commission
         pursuant  to Section  13(a),  13(c),  14 or 15(d) of the  Exchange  Act
         subsequent to the date of this Registration  Statement and prior to the
         filing of a  post-effective  amendment  hereto which indicates that all
         securities  offered have been sold or which  deregisters all securities
         then remaining unsold,  shall be deemed to be incorporated by reference
         herein  and to be a part  hereof  from  the  date  of  filing  of  such
         documents

ITEM 4.  DESCRIPTION OF SECURITIES.

         Not applicable.

ITEM 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL.

         The validity of the common stock offered hereby will be passed upon for
the  Registrant by Jonathan  Leinwand,  P.A. None of Jonathan  Leinwand,  P.A.'s
attorneys beneficially own any stock in Innovative.

         The  financial  statements  and  schedules  for the  fiscal  year ended
December 31, 2000 that are  incorporated  by reference  in this  Prospectus  and
elsewhere in this Registration Statement have been audited by DiRocco & Dombrow,
P.A.,  independent  certified  public  accountants,  to the  extent  and for the
periods indicated in their report,  and are included herein in reliance upon the
authority  of said firm as experts in  accounting  and  auditing  in giving such
reports.

ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

          Innovative'  articles of incorporation,  as amended,  provide that the
Company may indemnify any director,  officer,  employee,  fiduciary, or agent of
the Company to the full extent permitted by the Colorado  Corporation Code as in
effect at the time of the conduct by the person.

         An officer or director  of a Colorado  corporation  may be  indemnified
against  liability  occurred in any proceeding  related to that person's actions
while acting as an officer or director of the  corporation  if that person acted
in good faith; in the corporation's best interest or at least not opposed to the
corporation's  best interest;  and the person had no reasonable cause to believe
that his or her conduct was unlawful.

         An officer or director may not be  indemnified in a proceeding by or on
behalf of the  corporation  where the officer or director  was judged  liable or
where the officer or director  received  an  improper  personal  benefit and was
adjudged liable.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933, as amended (the "1933 Act") may be permitted to directors, officers
or controlling  persons of Registrant,  pursuant to the foregoing  provisions or
otherwise,  Registrant  has been advised that, in the opinion of the  Securities
and Exchange  Commission (the  "Commission"),  such  indemnification  is against
public policy as expressed in the 1933 Act, and is therefore  unenforceable.  In
the event that a claim for indemnification  against such liabilities (other than
the  payment by the  Registrant  of  expenses  incurred  or paid by a  director,
officer or  controlling  person of Registrant in the  successful  defense of any
suit or proceeding) is asserted by such director,  officer or controlling person
in connection with the securities being registered  hereunder,  Registrant will,
unless in the opinion of its counsel the matter has been settled by  controlling
precedent,  submit to a court of appropriate  jurisdiction  the question whether
such  indemnification  by it is  against  public  policy  as  expressed  in  the
Securities Act and will be governed by the final adjudication of such issue.


                                       10


ITEM 7.  EXEMPTION FROM REGISTRATION CLAIMED.

         The  restricted  shares of common stock that may be reoffered or resold
under this  registration  statement  were issued to the selling  shareholder  in
reliance upon the exemption  afforded under Section 4(2) of the Securities  Act.
The selling  shareholder  was provided  information  about the Registrant or had
access to such information, and the investor was provided the opportunity to ask
questions of Registrant's management concerning the information provided or made
available. The certificates representing the shares bears a legend accordingly.

ITEM 8.  EXHIBITS

         See "Exhibit Index" on page 13.

ITEM 9.  UNDERTAKINGS

         (a)      The undersigned registrant hereby undertakes:

                  (1) To file,  during any  period in which  offers or sales are
being made,  a  post-effective  amendment  to this  registration  statement,  to
include  any  additional  or  changed  material   information  on  the  plan  of
distribution.

                  (2)  For  the  purpose  of  determining  liability  under  the
Securities  Act, to treat each  post-effective  amendment as a new  registration
statement relating to the securities offered, and the offering of the securities
at that time shall be deemed to be the initial bona fide offering.

                  (3) To remove from  registration by means of a  post-effective
amendment  any of the  securities  being  registered  that remain  unsold at the
termination of the offering.

         (b) The undersigned  registrant hereby undertakes that, for purposes of
determining  any  liability  under  the  Securities  Act,  each  filing  of  the
registrant's  periodic reports pursuant to Section 13(a) or Section 15(d) of the
Exchange Act that is  incorporated  by reference in the  registration  statement
shall be deemed to be a new  registration  statement  relating to the securities
offered  therein,  and the  offering  of such  securities  at that time shall be
deemed to be the initial bona fide offering thereof.

         (c)  Insofar  as  indemnification  for  liabilities  arising  under the
Securities Act may be permitted to directors,  officers and controlling  persons
of the  registrant  pursuant to the  foregoing  provisions,  or  otherwise,  the
registrant  has been advised that in the opinion of the  Securities and Exchange
Commission  such  indemnification  is against  public policy as expressed in the
Securities Act and is, therefore,  unenforceable.  In the event that a claim for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  registrant  in the  successful  defense  of any  action,  suit or
proceeding)  is  asserted by such  director,  officer or  controlling  person in
connection with the securities being registered,  the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit  to a  court  of  appropriate  jurisdiction  the  question  whether  such
indemnification  by it is against  public policy as expressed in the  Securities
Act and will be governed by the final adjudication of such issue.

                   [REMAINDER OF PAGE LEFT BANK INTENTIONALLY]


                                       11


                                   SIGNATURES

         Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets
all of the  requirements  for  filing  on  Form  S-8 and has  duly  caused  this
Registration Statement to be signed on its behalf by the undersigned,  thereunto
duly authorized, in the City of Orlando, State of Florida, on April 16, 2001.

                                      INNOVATIVE HOLDINGS AND TECHNOLOGIES, INC.

                                      By:

                                      Helmut Wyzisk
                                      Chairman, President

         Pursuant to the requirements of the Securities Act of 1933, as amended,
this  Registration  Statement has been signed below by the following  persons in
the capacities and on the dates indicated.

      SIGNATURE                  TITLE                          DATE
      ---------                  -----                          ----
                           President, Director              April 16, 2001
- ----------------------    (principal executive officer)
     Helmut Wyzisk


                                       12


                                  EXHIBIT INDEX

                  EXHIBIT
                  -------
                  NUMBER                            DESCRIPTION
                  -------                            -----------

                   3.1            Registrant's Amended Articles of Incorporation

                   3.2            Registrant's Bylaws

                   5.1            Opinion of Jonathan D. Leinwand, P.A.

                  23.1            Consent of  DiRocco & Dombrow

                  23.2            Consent  of   Jonathan   D.   Leinwand,   P.A.
                                 (contained  in its  opinion  filed as  Exhibit
                                  5.1 hereto)


                                       13